| Report Title | Price | Action |
|---|---|---|
| Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021
Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 Summary Commun...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) - Drugs in Development, 2021
Transmembrane Protease Serine 2 (Serine Protease 10 or TMPRSS2 or EC 3.4.21.) - Drugs in Development, 2021 Summary Transmembrane Protease Serine 2 (...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Interferon Gamma (Immune Interferon or IFNG) - Drugs in Development, 2021
Interferon Gamma (Immune Interferon or IFNG) - Drugs in Development, 2021 Summary Interferon Gamma (Immune Interferon or IFNG) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021
Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 Summary Niemann Pick C1 Like Protein 1 (NPC1L1) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Focal Segmental Glomerulosclerosis (FSGS) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021
Focal Segmental Glomerulosclerosis (FSGS) (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 Summary Focal Segmental Glomeruloscl...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) - Drugs in Development, 2021
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type A (Genetic Disorders) - Drugs in Development, 2021 Summary Acid Sphingomyelinase Defici...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Raynauds Disease (Cardiovascular) - Drugs in Development, 2021
Raynauds Disease (Cardiovascular) - Drugs in Development, 2021 Summary Raynauds Disease (Cardiovascular) - Drugs in Development, 2021 provides an ov...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Community-Acquired Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021
Community-Acquired Bacterial Pneumonia (Infectious Disease) - Drugs in Development, 2021 Summary Community-Acquired Bacterial Pneumonia (Infectious ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Tyrosine Protein Kinase ABL1 (Abelson Murine Leukemia Viral Oncogene Homolog 1 or Abelson Tyrosine Protein Kinase 1 or Proto Oncogene c Abl or p150 or ABL1 or EC 2.7.10.2) - Drugs in Development, 2021
Tyrosine Protein Kinase ABL1 (Abelson Murine Leukemia Viral Oncogene Homolog 1 or Abelson Tyrosine Protein Kinase 1 or Proto Oncogene c Abl or p150 o...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) - Drugs in Development, 2021
Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1) - Drugs in Development, 2021 Summary Interferon Gamma Receptor 1 (CDw119 or CD119 or IFNGR1)...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Drugs in Development, 2021 Summary Integrin Alpha V (Vitronectin Receptor S...
Published: Apr-2021 | No. of Pages: 70
|
$ 3000 | |
| Cytokine Release Syndrome (Cytokine Storm) (Immunology) - Drugs in Development, 2021
Cytokine Release Syndrome (Cytokine Storm) (Immunology) - Drugs in Development, 2021 Summary Cytokine Release Syndrome (Cytokine Storm) (Immunology)...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021
Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021 Summary Alport Syndrome (Genetic Disorders) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021
Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs in Development, 2021 Summary Recurrent Glioblastoma Multiforme (GBM) (Oncology) - Drugs i...
Published: Apr-2021 | No. of Pages: 210
|
$ 2500 | |
| Complicated Intra-Abdominal Infections (Infectious Disease) - Drugs in Development, 2021
Complicated Intra-Abdominal Infections (Infectious Disease) - Drugs in Development, 2021 Summary Complicated Intra-Abdominal Infections (Infectious ...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation (Platelet Receptor Gi24 or Stress Induced Secreted Protein 1 or PD1H or V Set Domain Containing Immunoregulatory Receptor or B7H5 or VISTA or VSIR) - Drugs in Development, 2021
V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation (Platelet Receptor Gi24 or Stress Induced Secreted Protein 1 or PD1H or V Set ...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Interleukin 1 Receptor Like 2 (IL 36 Receptor or Interleukin 1 Receptor Related Protein 2 or IL1RL2) - Drugs in Development, 2021
Interleukin 1 Receptor Like 2 (IL 36 Receptor or Interleukin 1 Receptor Related Protein 2 or IL1RL2) - Drugs in Development, 2021 Summary Interleuki...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Drugs in Development, 2021
Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Drugs in Development, 2021 Summary ...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
| Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021
Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 Summary Diastolic Heart Failure (Cardiovascular) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| Charcot-Marie-Tooth Disease Type II (Genetic Disorders) - Drugs in Development, 2021
Charcot-Marie-Tooth Disease Type II (Genetic Disorders) - Drugs in Development, 2021 Summary Charcot-Marie-Tooth Disease Type II (Genetic Disorders)...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 |